{"organizations": [], "uuid": "f22234727c5df74a6145a8f889a8dbb8cde16e6d", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180213.html", "section_title": "Archive News &amp; Video for Tuesday, 13 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-shandong-shanda-wit-science-and-te/brief-shandong-shanda-wit-science-and-technology-to-acquire-1-1-mln-shares-of-biopharmaceuticals-unit-idUSL4N1Q34DD", "country": "US", "domain_rank": 408, "title": "Shandong Shanda Wit Science and Technology to acquire 1.1 mln shares of biopharmaceuticals unit", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-13T19:44:00.000+02:00", "replies_count": 0, "uuid": "f22234727c5df74a6145a8f889a8dbb8cde16e6d"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-shandong-shanda-wit-science-and-te/brief-shandong-shanda-wit-science-and-technology-to-acquire-1-1-mln-shares-of-biopharmaceuticals-unit-idUSL4N1Q34DD", "ord_in_thread": 0, "title": "Shandong Shanda Wit Science and Technology to acquire 1.1 mln shares of biopharmaceuticals unit", "locations": [], "entities": {"persons": [], "locations": [{"name": "beijing", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "shandong shanda wit science and technology co ltd", "sentiment": "negative"}, {"name": "shandong shanda wit science and technology", "sentiment": "negative"}, {"name": "thomson reuters trust principles", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 13(Reuters) - Shandong Shanda Wit Science and Technology Co Ltd\n* Says it plans to acquire 1.1 million shares of Shandong-based biopharmaceuticals unit\n* Says it will hold 52.1 percent stake (32.3 million shares) in the unit after acquisition\nSource text in Chinese: goo.gl/Z3h21T\nFurther company coverage: (Beijing Headline News)\n ", "external_links": ["https://goo.gl/Z3h21T", "http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-13T19:44:00.000+02:00", "crawled": "2018-02-14T12:43:37.000+02:00", "highlightTitle": ""}